Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Ampersand Capital Partners
AddedFeb 15, 2024
UpdatedJun 28, 2026
Ampersand Capital Partners

Ampersand Capital Partners

Operating

Ampersand Management LLC: A private equity firm specializing in healthcare investments in the US.

Location
Wellesley, MA, US
Founded
1988
Firm
Compare
Portfolio
Fundraising
Employees
Website

Ampersand Capital Partners is a Boston-based private equity firm specializing in healthcare investments. With a focus on lower middle market companies in the United States, they typically invest in businesses with revenues ranging from $10 to $200 million. Ampersand's equity investments usually fall between $10 and $200 million per deal.

The firm boasts over 25 years of experience in healthcare investing and leverages its sector expertise and extensive operating networks to support entrepreneurs. Notable portfolio companies include AnaBios, Arranta Bio, and Vernal Biosciences. Ampersand's investment strategy spans various stages, from Series A to later rounds, demonstrating their commitment to long-term growth and value creation in the healthcare sector.

Ampersand Capital Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments17
Current Portfolio Count8
Total Portfolio Exits1

Top Investment Stages

Series A4 (28.6%)
Series B3 (21.4%)
Series Unknown3 (21.4%)
Series C2 (14.3%)
Series D2 (14.3%)

Stage Mix

Series A 29%Series B 21%Series Unknown 21%Series C 14%Series D 14%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Vernal Biosciences logo

Vernal Biosciences

AnaBios logo

AnaBios

Arranta Bio logo

Arranta Bio

Bioventus logo

Bioventus

NutraMed logo

NutraMed

Nitinol Devices & Components logo

Nitinol Devices & Components

Medifacts International logo

Medifacts International

Proficiency logo

Proficiency

Silicon Wave logo

Silicon Wave

Blackstone Technology Group logo

Blackstone Technology Group

Ampersand Capital Partners - Similar Investment Firms

Amicus Capital Partners logo

Amicus Capital Partners

Venture Equity Partners logo

Venture Equity Partners

Health2047 Capital Partners logo

Health2047 Capital Partners

A&M Capital Partners logo

A&M Capital Partners

a-mcapital.com

Ambina Partners logo

Ambina Partners

ambina.com

Berkshire Partners logo

Berkshire Partners

Summit Partners logo

Summit Partners

summitpartners.com

Enhanced Healthcare Partners logo

Enhanced Healthcare Partners

Vesey Street Capital Partners logo

Vesey Street Capital Partners

vscpllc.com

Concord Health Partners logo

Concord Health Partners

concordhp.com

Boston Millennia Partners logo

Boston Millennia Partners

Vestar Capital Partners logo

Vestar Capital Partners

vestarcapital.com

Amulet Capital Partners logo

Amulet Capital Partners

amuletcapital.com

Andera Partners logo

Andera Partners

anderapartners.com

Amplitude Ventures logo

Amplitude Ventures

amplitudevc.com

Ampersand Capital Partners - Classification

Also Known As
  • Ampersand Management LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end